EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden of acute lymphoblastic leukemia in children and adolescents in low- and middle-income countries from 1990 to 2023 and projections to 2050: A systematic analysis from the global burden of disease study 2023

Peng Liu iD, ZiXin Xu, Wenfu Song, Jianxiong Yang, Jianbao Li

PLOS One · 02.06.2026 · 21 (6) · e0350223

DOI: 10.1371/journal.pone.0350223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 02.06.2026. Verfasst von Peng Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Global Burden of Disease. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute Lymphoblastic Leukemia (ALL) is the most common and curable malignancy in children and adolescents, yet it remains a significant health threat. Despite global survival improvements driven by new drugs and treatment protocols, comprehensive data on disease burdens and attributable risk factors across diverse socio-economic contexts remain limited. This study evaluated the epidemiological characteristics, temporal trends, and modeled attributable risk factors of ALL in LMICs from 1990 to 2023.

Methods

Using GBD 2023 data, we analyzed ALL incidence, mortality, and DALYs in children and adolescents (0–19 years), stratified by World Bank income groups. We assessed temporal trends via Joinpoint regression, projected burdens to 2050 using the Bayesian Age-Period-Cohort (BAPC) model, and evaluated risk attribution for occupational benzene and formaldehyde exposure.

Results

In 2023, LMICs reported 64,477 new ALL cases and 30,909 deaths, with a higher burden in males. While the age-standardized incidence rate (ASIR) declined overall, absolute cases rose due to population growth. Although occupational benzene and formaldehyde exposure were the only modeled risk factors, their Population Attributable Fractions (PAFs) were negligible (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaGlobal Burden of DiseaseHumansAdolescentChildMaleChild, PreschoolInfantFemaleDeveloping CountriesIncidenceInfant, NewbornRisk FactorsYoung AdultBenzeneFormaldehydeOccupational ExposureDisability-Adjusted Life Years

Substanzen

BenzeneFormaldehyde

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Departmalest of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID-Profile: Peng Liu

Zitieren

APA

Liu, P., Xu, Z., Song, W., Yang, J., & Li, J. (2026). Burden of acute lymphoblastic leukemia in children and adolescents in low- and middle-income countries from 1990 to 2023 and projections to 2050: A systematic analysis from the global burden of disease study 2023. PLOS One, 21(6), e0350223. https://doi.org/10.1371/journal.pone.0350223

Vancouver

Liu P, Xu Z, Song W, Yang J, Li J. Burden of acute lymphoblastic leukemia in children and adolescents in low- and middle-income countries from 1990 to 2023 and projections to 2050: A systematic analysis from the global burden of disease study 2023. PLOS One. 2026;21(6):e0350223. doi:10.1371/journal.pone.0350223

BibTeX
@article{Liu2026,
  author = {Liu, Peng and Xu, ZiXin and Song, Wenfu and Yang, Jianxiong and Li, Jianbao},
  title = {Burden of acute lymphoblastic leukemia in children and adolescents in low- and middle-income countries from 1990 to 2023 and projections to 2050: A systematic analysis from the global burden of disease study 2023},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0350223},
  doi = {10.1371/journal.pone.0350223}
}
Kostenlos starten →